Growth Metrics

Staar Surgical (STAA) Cost of Revenue (2016 - 2026)

Staar Surgical's Cost of Revenue history spans 17 years, with the latest figure at $14.1 million for Q1 2026.

  • For Q1 2026, Cost of Revenue fell 18.74% year-over-year to $14.1 million; the TTM value through Jan 2026 reached $78.4 million, down 16.14%, while the annual FY2026 figure was $57.0 million, 23.27% down from the prior year.
  • Cost of Revenue reached $14.1 million in Q1 2026 per STAA's latest filing, down from $23.5 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $32.3 million in Q2 2023 to a low of $14.1 million in Q1 2026.
  • Average Cost of Revenue over 5 years is $20.9 million, with a median of $18.9 million recorded in 2024.
  • Peak YoY movement for Cost of Revenue: surged 87.34% in 2023, then crashed 45.39% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $14.3 million in 2022, then increased by 9.04% to $15.5 million in 2023, then increased by 11.28% to $17.3 million in 2024, then surged by 35.6% to $23.5 million in 2025, then plummeted by 40.07% to $14.1 million in 2026.
  • Per Business Quant, the three most recent readings for STAA's Cost of Revenue are $14.1 million (Q1 2026), $23.5 million (Q3 2025), and $26.3 million (Q2 2025).